Free Trial

AG2R LA Mondiale Gestion D Actifs Acquires 816 Shares of Waters Corporation $WAT

Waters logo with Medical background

Key Points

  • AG2R LA Mondiale Gestion D Actifs has increased its stake in Waters Corporation by 27.0%, owning a total of 3,835 shares valued at approximately $1,339,000.
  • Waters Corporation reported earnings of $2.29 per share for the last quarter with revenue of $608.55 million, demonstrating a return on equity of 38.60%.
  • Analyst ratings for Waters include two "Strong Buy", six "Buy", and nine "Hold" recommendations, with an average target price of $376.80.
  • Five stocks to consider instead of Waters.

AG2R LA Mondiale Gestion D Actifs increased its stake in Waters Corporation (NYSE:WAT - Free Report) by 27.0% during the second quarter, according to its most recent filing with the SEC. The fund owned 3,835 shares of the medical instruments supplier's stock after buying an additional 816 shares during the quarter. AG2R LA Mondiale Gestion D Actifs' holdings in Waters were worth $1,339,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in the stock. Olde Wealth Management LLC purchased a new position in Waters in the first quarter valued at about $25,000. Zions Bancorporation National Association UT purchased a new position in Waters in the first quarter valued at approximately $28,000. IFP Advisors Inc lifted its stake in Waters by 118.9% in the first quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier's stock valued at $30,000 after purchasing an additional 44 shares during the last quarter. Caitong International Asset Management Co. Ltd bought a new position in Waters during the first quarter valued at $41,000. Finally, Steph & Co. purchased a new stake in Waters in the second quarter worth $73,000. Hedge funds and other institutional investors own 94.01% of the company's stock.

Waters Price Performance

NYSE:WAT opened at $358.79 on Friday. Waters Corporation has a 52-week low of $275.05 and a 52-week high of $423.56. The stock has a fifty day moving average of $311.56 and a 200 day moving average of $323.92. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.22 and a current ratio of 1.75. The firm has a market capitalization of $21.36 billion, a price-to-earnings ratio of 32.35, a P/E/G ratio of 3.34 and a beta of 1.04.

Waters (NYSE:WAT - Get Free Report) last announced its earnings results on Thursday, May 19th. The medical instruments supplier reported $2.29 earnings per share for the quarter. The business had revenue of $608.55 million for the quarter. Waters had a return on equity of 38.60% and a net margin of 21.71%. On average, research analysts expect that Waters Corporation will post 12.86 EPS for the current fiscal year.

Analyst Ratings Changes

Several research analysts have recently weighed in on WAT shares. Redburn Partners set a $390.00 price target on Waters in a research note on Wednesday, October 8th. Wall Street Zen downgraded shares of Waters from a "buy" rating to a "hold" rating in a research note on Saturday, July 26th. Rothschild Redb raised shares of Waters to a "strong-buy" rating in a research report on Wednesday, October 8th. Rothschild & Co Redburn started coverage on shares of Waters in a report on Wednesday, October 8th. They issued a "buy" rating and a $390.00 price objective for the company. Finally, Weiss Ratings reissued a "hold (c)" rating on shares of Waters in a report on Friday. Two analysts have rated the stock with a Strong Buy rating, six have given a Buy rating and nine have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, Waters has an average rating of "Moderate Buy" and an average target price of $376.80.

View Our Latest Analysis on Waters

Waters Profile

(Free Report)

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

See Also

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WAT - Free Report).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Waters Right Now?

Before you consider Waters, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.

While Waters currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.